Candid Therapeutics
Clinical trials sponsored by Candid Therapeutics, explained in plain language.
-
New drug trial offers hope for muscle weakness sufferers
Disease control Recruiting nowThis study is testing a new medicine called cizutamig in people with generalized myasthenia gravis (gMG), a condition that causes muscle weakness. The main goal is to check if the drug is safe and how the body processes it. About 44 adults with moderate to severe symptoms who hav…
Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New lupus drug candidate enters human safety testing
Disease control Recruiting nowThis study is testing a new medicine, cizutamig, in people with systemic lupus erythematosus (SLE). The main goal is to check if it is safe and how the body handles it. About 47 adults with active lupus who have not responded well enough to other treatments will take part. This i…
Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Disease control
Last updated May 06, 2026 16:15 UTC